凯德诊断 CDNA
$78.56 +$2.23 (+2.92%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $78.49 -0.09%
开盘$77.88
昨收$76.33
当日区间$75.93 – $80.55
成交量1.13M
市值$4.13B
市盈率（TTM）33.1
股息率–
财报
财报日平均波动±11.4%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+34.1%
最差反应-11.2%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | After Market | ±14.9% | +22.22% | 超出定价预期 |
| 2026/Q2 | 30 Jul 2026 | After Market | ±13.8% | +14.72% | 超出定价预期 |
| 2026/Q1 | 28 Apr 2026 | After Market | ±19.2% | -5.07% | 符合区间 |
| 2025/Q4 | 24 Feb 2026 | After Market | ±18.6% | -4.10% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±30.5% | +13.84% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±21.9% | -7.86% | 符合区间 |
| 2025/Q1 | 30 Apr 2025 | After Market | ±24.2% | -10.72% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±20.1% | -0.19% | 符合区间 |
| 2024/Q3 | 4 Nov 2024 | After Market | ±22.2% | -0.13% | 符合区间 |
| 2024/Q2 | 31 Jul 2024 | After Market | ±22.1% | +17.96% | 符合区间 |
| 2024/Q1 | 9 May 2024 | After Market | ±20.7% | +34.09% | 超出定价预期 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±21.0% | +9.47% | 符合区间 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±28.6% | +13.90% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±29.3% | -11.23% | 符合区间 |
| 2023/Q1 | 10 May 2023 | After Market | ±26.0% | -2.68% | 符合区间 |
| 2022/Q4 | 27 Feb 2023 | After Market | ±28.8% | +14.34% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$139.36M+39.3% YoY
营业利润$8.11M+3,397.6% YoY
净利润$19.29M+1,051.8% YoY
摊薄每股收益$0.35+1,066.7% YoY
自由现金流$11.10M-68.6% YoY
经营现金流$12.72M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率71.0%
营业利润率0.8%
净利率25.9%
净资产收益率33.0%
资产收益率24.0%
投入资本回报率29.7%
流动比率2.31
负债/资产比率27.1%
现金及投资$250.48M
总负债$20.32M
净现金（净负债）$230.16M
自由现金流/营收12.0%
暂无评论——快来第一个聊聊 CDNA。